Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Yuen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Andrology|April 28, 2021
Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy menFiona Yuen, Arthi Thirumalai, Frances A Fernando, et al.
Contraception|April 17, 2020
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototypeBrian T Nguyen, Maritza T Farrant, Bradley D Anawalt, et al.
Contraception|June 21, 2021
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trialBrian T Nguyen, Fiona Yuen, Maritza Farrant, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2020
Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy MenFiona Yuen, Arthi Thirumalai, Cindy Pham, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in MenSherry Wu, Fiona Yuen, Ronald S Swerdloff, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Andrology|April 28, 2021
Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy menFiona Yuen, Arthi Thirumalai, Frances A Fernando, et al.
Contraception|April 17, 2020
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototypeBrian T Nguyen, Maritza T Farrant, Bradley D Anawalt, et al.
Contraception|June 21, 2021
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trialBrian T Nguyen, Fiona Yuen, Maritza Farrant, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2020
Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy MenFiona Yuen, Arthi Thirumalai, Cindy Pham, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in MenSherry Wu, Fiona Yuen, Ronald S Swerdloff, et al.
Pageof 2